Skip to content

Author

Esra Kıratlı Nalbant

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Gastrointestinal safety signals of Janus kinase inhibitors: a real-world pharmacovigilance study using Food and Drug Administration Adverse Event Reporting System.

BACKGROUND Janus kinase inhibitors (JAKis) are increasingly used in dermatology, yet their gastrointestinal safety profiles remain incompletely characterized in real-world practice. Although gastrointestinal adverse events (GIAEs) are generally mild, gastrointestinal perforation remains an important safety concern with...

Esra Kıratlı Nalbant, Banu İsmail Mendi · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.